NUCLEAR IMAGING IN PULMONARY HYPERTENSION
https://doi.org/10.38109/2225-1685-2017-1-50-56
Abstract
About the Authors
V. B. SergienkoRussian Federation
D.Sc., Prof., chief of the nuclear medicine department
121552, Russia, Moscow, 3rd Cherepkovskaya str., Building 15 a
E. G. Valeeva
Russian Federation
PhD student, department of hypertension
121552, Russia, Moscow, 3rd Cherepkovskaya str., Building 15 a
References
1. Sergienko V.B., Ansheles A.A. Nuclear imaging in cardiology / Ed. Chazov E.I. M.: Practika, 2014. P. 571-612. [in Russian]
2. Bossone E., Dellegrottaglie S., Patel S., et al. Multimodality imaging in pulmonary hypertension. Can J Cardiol. 2015. Vol. 31. N. 4. P. 440-459.
3. Lishmanov Yu.B., Yefimova I.Yu., Chernov V.I., et al. Scintigraphy as a tool of diagnosis, prevention and monitoring of cardiac diseases treatment. Siberian Medical Journal 2007. 22(3): 74-77. [in Russian]
4. Galie N., Humbert M., Vachiery J.L., et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Respir J. 2015. Vol. 46. N. 4. P. 903-975.
5. Chazova I.E., Martynyuk T.V. Clinical guidelines for the diagnosis and treatment of chronic thromboembolic pulmonary hypertension (Part I). Terapevticheskij Arkhiv. 2016. 88 (9): 90-101. [in Russian]
6. Chazova I.E., Martynyuk T.V. Clinical guidelines for the diagnosis and treatment of chronic thromboembolic pulmonary hypertension (Part II). Terapevticheskij Arkhiv. 2016. 88(10): 63-73. [in Russian]
7. Torbicki A., Perrier A., Konstantinides S., et al. Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J. 2008. Vol. 29. N. 18. P. 2276-2315.
8. Lishmanov Y.B., Krivonogov N.G., Ilyushenkova Y.N. et al. Scintigraphic assessment of structural and functional changes of the myocardium and alveolar-capillary lung permeability in patients with community-acquired pneumonia. Siberian Medical Journal. 2011. 26(1): 106-109. [in Russian]
9. Gargiulo P., Cuocolo A., Dellegrottaglie S., et al. Nuclear assessment of right ventricle. Echocardiography. 2015. Vol. 32 Suppl 1. N. P. S69-74.
10. Corbett J.R., Akinboboye O.O., Bacharach S.L., et al. Equilibrium radionuclide angiocardiography. J Nucl Cardiol. 2006. Vol. 13. N. 6. P. 56-79.
11. Chazova I.E., Avdeev S.N., Tsareva N.A. et al. Clinical guidelines for the diagnosis and treatment of pulmonary hypertension. Terapevticheskij Arkhiv. 2014. 86(9): 4-23. [in Russian]
12. Hesse B., Lindhardt T.B., Acampa W. et al. EANM/ESC guidelines for radionuclide imaging of cardiac function. Eur J Nucl Med Mol Imaging. 2008. Vol. 35. N. 4. P. 851-885.
13. Zavadovsky K.V., Pankov A.N. Scintigraphic assessment of right ventricle dysfunction in patients with pulmonary embolism. Medical imaging. 2009. 3: 24-30. [in Russian]
14. Verrier R.L., Antzelevitch C. Autonomic aspects of arrhythmogenesis: the enduring and the new. Curr Opin Cardiol. 2004. Vol. 19. N. 1. P. 2-11.
15. Ansheles A.A., Schigoleva Y.V., Sergienko I.V. et al. SPECT myocardial perfusion and sympathetic innervation in patients with hypertrophic cardiomyopathy. Kardiologicheskij Vestnik. 2016. XI(1): 24-33. [in Russian]
16. Matsushita T., Ikeda S., Miyahara Y., et al. Use of [123I]-BMIPP myocardial scintigraphy for the clinical evaluation of a fatty-acid metabolism disorder of the right ventricle in chronic respiratory and pulmonary vascular disease. J Int Med Res. 2000. Vol. 28. N. 3. P. 111-123. [in Russian]
17. Bokhari S., Raina A., Rosenweig E.B., et al. PET imaging may provide a novel biomarker and understanding of right ventricular dysfunction in patients with idiopathic pulmonary arterial hypertension. Circ Cardiovasc Imaging. 2011. Vol. 4. N. 6. P. 641-647.
18. Arkhipova O.A., Martynyuk T.V., Valeeva E.G. et al. Myocardial ischemia in patients with pulmonary arterial hypertension. Sistemnye Gipertenzii. 2015. 4: 52-56. [in Russian]
19. Vogel-Claussen J., Skrok J., Shehata M.L., et al. Right and left ventricular myocardial perfusion reserves correlate with right ventricular function and pulmonary hemodynamics in patients with pulmonary arterial hypertension. Radiology. 2011. Vol. 258. N. 1. P. 119-127.
20. Sergienko V.B., Ansheles A.A. Tomographic methods in the assessment of myocardial perfusion. Vestnik rentgenologii i radiologii 2010. 3: 10-14. [in Russian]
21. Ansheles A.A., Shulgin D.N., Solomyany V.V. et al. Comparison of stress-test, single-photon emission computed tomography, and coronarography results in IHD patients. Kardiologicheskij Vestnik 2012. 2: 10-17. [in Russian]
22. Ansheles A.A., Shulgin D.N., Solomyany V.V. et al. Clinical significance of nuclear medicine in selection of CHD patients to coronary angiography. Terapevt. 2012. 9: 34-41. [in Russian]
23. Ansheles A.A., Sergienko V.B. Current possibilities of nuclear imaging in arterial hypertension. Sistemnye gipertenzii. 2016. 13 (1): 22-28. [in Russian]
24. Gomez A., Bialostozky D., Zajarias A., et al. Right ventricular ischemia in patients with primary pulmonary hypertension. J Am Coll Cardiol. 2001. Vol. 38. N. 4. P. 1137-1142.
25. Sergienko V.B., Ansheles A.A., Shulgin D.N. et al. Guidelines: myocardial perfusion scintigraphy and SPECT. Kardiologicheskii vestnik. 2015. 2: 6-21. [in Russian]
26. Ansheles A.A., Khalikova E.I., Ryzhikova O.A. New method of quantitative assessment of myocardial perfusion disorders according to single-photon emission computed tomography. Medical Physics. 2016. 69(1):46-53. [in Russian]
27. Ohira H., Beanlands R.S., Davies R.A., et al. The role of nuclear imaging in pulmonary hypertension. J Nucl Cardiol. 2015. Vol. 22. N. 1. P. 141-157.
28. Mazraeshahi R.M., Striet J., Oeltgen R.C., et al. Myocardial SPECT images for diagnosis of pulmonary hypertension and right ventricular hypertrophy. J Nucl Med Technol. 2010. Vol. 38. N. 4. P. 175-180.
29. Maedera M.T., Stöcklib M., Zellweger M.J. Myocardial perfusion SPECT features of severe pulmonary artery hypertension. Kardiovaskuläre Medizin. 2007. Vol. 10. N. P. 113-114.
30. Gibbons Kroeker C.A., Adeeb S., Shrive N.G., et al. Compression induced by RV pressure overload decreases regional coronary blood flow in anesthetized dogs. Am J Physiol Heart Circ Physiol. 2006. Vol. 290. N. 6. P. H2432-2438.
31. Oikawa M., Kagaya Y., Otani H., et al. Increased [18F] fluorodeoxyglucose accumulation in right ventricular free wall in patients with pulmonary hypertension and the effect of epoprostenol. J Am Coll Cardiol. 2005. Vol. 45. N. 11. P. 1849-1855.
32. Sergienko V.B., Nonikov V.E. Emission computed tomography in pulmonology. Terapevticheskij Arkhiv. 1984. 3: 122-125. [in Russian]
33. Ansheles A.A., Sergienko V.B. Diagnostic imaging modalities in myocardial perfusion assessment in patients with ischemic heart disease. Nuclear Medicine and Radiation Safety. 2011. 3: 74-79. [in Russian]
34. Ansheles, A.A. Specific features of interpretation of myocardial perfusion single-photon emission computed tomography with computed tomographic absorption correction. Vestnik rentgenologii i radiologii. 2014. 2: 5-20. [in Russian]
Review
For citations:
Sergienko V.B., Valeeva E.G. NUCLEAR IMAGING IN PULMONARY HYPERTENSION. Eurasian heart journal. 2017;(1):50-56. (In Russ.) https://doi.org/10.38109/2225-1685-2017-1-50-56